DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Schaffner D, Lazaro A, Deibert P. , et al.
Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
World J Gastroenterol 2018;
24 (38) 4356-4368
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.